期刊文献+

2007年至2011年我院门诊核苷类抗病毒药应用分析 被引量:2

Outpatient Application of Nucleotide Antiviral Drugs in Our Hospital from 2007 to 2011
下载PDF
导出
摘要 目的调查医院门诊核苷类抗病毒药的应用情况,分析其发展趋势,为临床合理用药提供参考。方法对医院门诊核苷类抗病毒药的销售数量、金额、用药频度(DDDs)、日均费用(DDC)等进行统计、分析。结果核苷类抗病毒药的销售数量、金额、DDDs均呈逐年增长趋势。结论医院核苷类抗病毒药应用基本合理,符合用药特点,但用药时应关注不良反应的发生,使用药更加安全、有效、经济、合理。 Objective To investigate the application situation of nucleotide antiviral drugs in the outpatient department of our hospital during 2007-2011 ,and to analyze its development trend so as to provide reference for their clinical rational use. Methods The con- sumption quantity,amount of money,DDDS and DDC of nucleotide antiviral drugs in the outpatient department of our hospital were sta- tistically analyzed. Results The consumption quantity, amount of money and DDDS of nucleotide antiviral drugs kept the increasing trend year by year. Conclusion The application of nucleotide antiviral drugs is reasonable on the whole and in line with the character- istics of medication,but the adverse drug reactions(ADRs) should be given fully attention to facilitate the safer, effective, economical and reasonable drug use.
作者 马燕
出处 《中国药业》 CAS 2014年第1期46-47,共2页 China Pharmaceuticals
关键词 乙型肝炎病毒 核苷类抗病毒药 用药频度 用药分析 HBV nucleotide antiviral drugs DDDs medication analysis
  • 相关文献

参考文献7

二级参考文献36

  • 1张继春,金岩,李大魁,彭名炜.北京地区主要抗生素使用频度分析[J].中国药学杂志,1994,29(6):373-376. 被引量:34
  • 2刘屏,张志萍,陈宜鸿,孙映和,颜青,李辉.我院门诊处方中抗菌药物使用研究[J].中国药房,1995,6(2):23-24. 被引量:15
  • 3Van Geyt C,De Gendt S,Rombout A,et al.Aline probe assay for hepatitis B virus genotypes.In:Schinazi RFS,Sommadossi J-P,Thomas HC,editors,Therapies for viral hepatitis.London:International Medical Press,1998:139-145. 被引量:1
  • 4Naito H,Hayashi S,Abe K.Papid and specific genotyping system for hepatitis B virucorresponding to six major genotypes by PCR using type-pecific primers.J Clin Microbiol,2001,39(1):362-364. 被引量:1
  • 5Usuda S,Okamoto H,Tanaka T,et al.Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product.J Virol Methods,2000,87:81-89. 被引量:1
  • 6姚桢.中国医药科技出版社,1998:138-145. 被引量:1
  • 7GANEM D,PRINCE A M.Hepatitis B virus infection--natural history and clinicalconsequences[J].N Engl J Med,2004,350(11):1118-1129. 被引量:1
  • 8LOK A S,MCMAHON B J.The American Association for the Study of Liver Diseases(AASLD).Chronic hepatitis B[J].J Hepatology,2007,45(10):507-539. 被引量:1
  • 9European Association for the Study of the Liver.EASL clinical practiceguidelines:Management of chronic hepatitis B[J].J Hepatol,2009,50(2):227-242. 被引量:1
  • 10LIAW Y F,LEUNG N,KAO J H,et al.Asian-Pacific consensus statement on the management of chronic hepatitis B:a 2008 update[J].Hepatol Int,2008,2(3):263-283. 被引量:1

共引文献1441

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部